ATE239503T1 - Lösungen für die peritonealdialyse und deren verwendung zum verringern von schädigungen an mesothelialen zellen - Google Patents

Lösungen für die peritonealdialyse und deren verwendung zum verringern von schädigungen an mesothelialen zellen

Info

Publication number
ATE239503T1
ATE239503T1 AT97201673T AT97201673T ATE239503T1 AT E239503 T1 ATE239503 T1 AT E239503T1 AT 97201673 T AT97201673 T AT 97201673T AT 97201673 T AT97201673 T AT 97201673T AT E239503 T1 ATE239503 T1 AT E239503T1
Authority
AT
Austria
Prior art keywords
mesothelial cells
peritoneal dialysis
reduce damage
peritoneal
dialysis solutions
Prior art date
Application number
AT97201673T
Other languages
English (en)
Inventor
Andrzej Breborowicz
Dimirios G Oreopulos
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Application granted granted Critical
Publication of ATE239503T1 publication Critical patent/ATE239503T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97201673T 1992-02-04 1993-02-04 Lösungen für die peritonealdialyse und deren verwendung zum verringern von schädigungen an mesothelialen zellen ATE239503T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83072192A 1992-02-04 1992-02-04

Publications (1)

Publication Number Publication Date
ATE239503T1 true ATE239503T1 (de) 2003-05-15

Family

ID=25257564

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97201673T ATE239503T1 (de) 1992-02-04 1993-02-04 Lösungen für die peritonealdialyse und deren verwendung zum verringern von schädigungen an mesothelialen zellen
AT93300846T ATE169223T1 (de) 1992-02-04 1993-02-04 Peritonealdialyselösungen die mindestens ein dipeptid enthalten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT93300846T ATE169223T1 (de) 1992-02-04 1993-02-04 Peritonealdialyselösungen die mindestens ein dipeptid enthalten

Country Status (8)

Country Link
US (2) US5597805A (de)
EP (2) EP0804931B1 (de)
JP (1) JP3262620B2 (de)
AT (2) ATE239503T1 (de)
DE (2) DE69320078T2 (de)
DK (1) DK0555087T3 (de)
ES (1) ES2121941T3 (de)
GR (1) GR3027714T3 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
DE69320078T2 (de) * 1992-02-04 1999-03-25 Baxter International Inc., Deerfield, Ill. 60015 Peritonealdialyselösungen die mindestens ein Dipeptid enthalten
ATE226433T1 (de) * 1992-12-22 2002-11-15 Baxter Int Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse
CA2155910C (en) * 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
EP1009452A4 (de) 1997-08-07 2004-03-31 Ajay Gupta Wasserlösliche vitamine und nährstoffe enthaltende dialyselösung
EP0958832B1 (de) 1998-05-21 2006-01-25 Nipro Corporation Albumin enthaltende Lösung für die Peritonealdialyse
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
AU4553700A (en) 1999-04-26 2000-11-10 Pe Chou Chang Substitution infusion fluid and citrate anticoagulation
US7033498B2 (en) * 2000-11-28 2006-04-25 Renal Solutions, Inc. Cartridges useful in cleaning dialysis solutions
US6627164B1 (en) 2000-11-28 2003-09-30 Renal Solutions, Inc. Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
US6878283B2 (en) * 2001-11-28 2005-04-12 Renal Solutions, Inc. Filter cartridge assemblies and methods for filtering fluids
WO2003055481A1 (en) * 2001-12-25 2003-07-10 Ajinomoto Co., Inc. Organ fibrosis inhibitors
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
US20100286085A1 (en) 2007-10-01 2010-11-11 Seikagaku Corporation Novel chondroitin sulfate having decreased molecular weight and use thereof
CN102596982B (zh) * 2009-03-31 2015-03-18 Cci有限公司 腹膜肥厚抑制剂
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
CA2935791C (en) 2014-03-17 2018-02-27 Fresenius Medical Care Holdings, Inc. Cartridges useful in cleaning dialysis solutions
WO2017048358A1 (en) 2015-09-16 2017-03-23 Fresenius Medical Care Holdings, Inc. Cartridges useful in cleaning dialysis solutions
WO2017053328A1 (en) 2015-09-21 2017-03-30 The Board Of Trustees Of The Leland Stanford Junior University Nutritional treatment for cancer
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione
JP7428655B2 (ja) 2017-12-11 2024-02-06 フィルトリシン， インコーポレイテッド がん処置および代謝介入治療のための組成物、方法、キットおよびシステム
GB202202728D0 (en) * 2022-02-28 2022-04-13 Invizius Ltd Peritoneal fluid composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
US4339433A (en) * 1981-01-09 1982-07-13 Baxter Travenol Laboratories, Inc. Additives for peritoneal dialysis solutions
US4574085A (en) * 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
US4761237A (en) * 1981-07-10 1988-08-02 Baxter Travenol Laboratories, Inc. Peritoneal dialysis solution containing carbohydrate polymers
US4886789A (en) * 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
JPS61247466A (ja) * 1985-04-25 1986-11-04 テルモ株式会社 腹膜透析用透析液
GB8521712D0 (en) * 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
DE3683583D1 (de) * 1985-09-10 1992-03-05 Res Corp Technologies Inc Osmotische mittel fuer peritonealdialyse.
US4976683A (en) * 1986-06-20 1990-12-11 Abbott Laboratories Peritoneal dialysis method
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
DE3812525C1 (de) * 1988-04-15 1989-06-22 Fresenius Ag, 6380 Bad Homburg, De
JPH02196724A (ja) * 1989-01-26 1990-08-03 Terumo Corp 腹膜透析液
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
DE69320078T2 (de) * 1992-02-04 1999-03-25 Baxter International Inc., Deerfield, Ill. 60015 Peritonealdialyselösungen die mindestens ein Dipeptid enthalten

Also Published As

Publication number Publication date
JP3262620B2 (ja) 2002-03-04
DE69320078T2 (de) 1999-03-25
DE69332959D1 (de) 2003-06-12
EP0804931A2 (de) 1997-11-05
US5597805A (en) 1997-01-28
EP0555087A1 (de) 1993-08-11
JPH05345021A (ja) 1993-12-27
GR3027714T3 (en) 1998-11-30
DK0555087T3 (da) 1999-05-03
US5955450A (en) 1999-09-21
DE69332959T2 (de) 2004-05-13
EP0804931A3 (de) 2001-04-11
EP0555087B1 (de) 1998-08-05
EP0804931B1 (de) 2003-05-07
DE69320078D1 (de) 1998-09-10
ATE169223T1 (de) 1998-08-15
ES2121941T3 (es) 1998-12-16

Similar Documents

Publication Publication Date Title
DE69332959D1 (de) Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen
FR2639233B1 (fr) Agent d'hygiene en hemodialyse
WO1992003202A3 (en) Medical drug formulation and delivery system
CA2140521A1 (en) Apparatus and Method for Preventing Hypotension in a Dialysis Patient
AU6950387A (en) Light array assembly for photoactivation patient treatment system
PT911043E (pt) Processo para a medicao de parametros de rendimento, de modulos de permuta de substancias e de energia
ATE300298T1 (de) Behandlung von leukocyten durch photopheresis
DE59409509D1 (de) Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate als Angiotensin II Antagonisten
TR26748A (tr) SU VE N-METIL-MORFOLIN-N-OKSIT ICINDE SELüLOZ CÖZELTISI.
IE821162L (en) Dialysis solution
SE9600631D0 (sv) Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
DE69624914D1 (de) Vorrichtung und verfahren für die biospezifische entfernung von heparin
Westhuyzen et al. Evidence for oxidative stress during in vitro dialysis
US20140346105A1 (en) Dialysate Regeneration System for Portable Human Dialysis
EP0839543A1 (de) Verfahren und Vorrichtung zur Desinfektion eines medizinischen Gerätes
DE69521388D1 (de) Verwendung von Glycosaminoglycanen zur Herstellung eines Arzneimittels zur Behandlung des chronischen Nierenversagens
ATE127787T1 (de) Nitratoalkancarbonsäure-derivate und verfahren zu ihrer herstellung.
JPH0686810A (ja) 血液浄化装置
FI932952A0 (fi) Imidazolylsubstituerade cyklohexanderivat
Milford et al. Resistance to Recombinant Human Erythropoietin in a Child with Renal Failure, Cystinosis and β-Thalassaemia Minor
ZA871411B (en) Irradiation chamber for photoactivation patient treatment system
KR20250119598A (ko) 복막 투석 소독 디바이스
JPH0413145U (de)
JPH0670978A (ja) 血液透析濾過装置
ATE98127T1 (de) Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties